MaxCyte Inc - MXCT Net earnings per share for the last 12 months

Public company logo of MaxCyte Inc. (MXCT)

MaxCyte, Inc. (MXCT) develops cell engineering technology, generating steady profits from the sale of proprietary components. This price chart from GURU.Markets illustrates the EPS TTM trend, which stands at 39.10. A Maryland-based facility with a specialized microclimate ensures high product quality, while leadership in electroporation methods provides a sustainable competitive advantage within the gene therapy sector.

MaxCyte - MXCT Earnings per share for the last twelve months (period 02/11/2024 - 11/12/2026)

MaxCyte, Inc - analytical breakdowns and key metrics (MXCT)

- market price and analyst price targets:
Market Chart maxcyte.com|MXCT - Analyst Consensus Forecast
- issuer market value details:
Market Valuation MaxCyte Inc.|MXCT - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share MaxCyte|MXCT - Company Book Value|Market Cap to Net Assets Ratio maxcyte.com|MXCT - Company Total Assets
- debt burden and liquidity indicators:
Debt to Capital MaxCyte, Inc.|MXCT - Long-Term Debt to Capital|Short-Term Debt to Capital Ratio MaxCyte Inc|MXCT - Company Aggregate Debts|Debts to Net Assets MaxCyte Inc.|MXCT - Company Long-Term Debts|Company Current Liabilities MaxCyte|Quick Ratio maxcyte.com
- financial results and valuation multiples details:
MXCT - Company Net Income|Expected Profit MaxCyte, Inc.|MXCT - Price to Earnings Ratio|Future Price to Earnings Multiple MaxCyte Inc.|MXCT - PEG Multiple|Company Value to EBITDA MaxCyte Inc.|MXCT - Profit before payment of interest, taxes and amortization|Net earnings per share for the trailing year MaxCyte|MXCT - Net earnings per share for the last 12 months|Quarterly EPS earnings growth maxcyte.com|MXCT - Earnings growth in current year|Consensus forecast of earnings per share growth for next year MaxCyte, Inc.
Fundamental company valuation:MXCT (maxcyte.com)
Core merchandise of maxcyte.com

For MaxCyte, Inc. (MXCT), the relative YoY (ttm) EPS change serves as an indicator of profitability dynamics over a rolling year. This metric aggregates twelve months of data into a continuous trend, neutralizing quarterly net income volatility. The sensitivity of this indicator allows for a real-time assessment of the efficiency of the consumable cartridge sales and royalty model. A positive vector here confirms the successful scaling of the medtech infrastructure and the growth of recurring margins.

Competitor analysis for MaxCyte, Inc.

Net earnings per share for the last four quarters abbott.com ABT|TMO: Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months GE HealthCare Technologies Inc.|Net earnings per share for the last 12 months MTD|WAT: Earnings per share for the trailing year|Earnings per share for the last twelve months Bio-Techne Corporation (TECH)|Net earnings per share for the last 12 months bruker.com BRKR|Net earnings per share (EPS TTM) AZTA (Azenta)|Varex Imaging Corp (VREX) - Net earnings per one share for the last twelve months|Semler Scientific Corp - Net earnings per share (EPS TTM)|BFLY (Butterfly Corp) - Earnings per share for the last 12 months|MLAB: Net earnings per share (EPS TTM)|QSI - Net earnings per share for the last four quarters|NNOX (Nano-X) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Quanterix Corp. (QTRX)|Net earnings per share (EPS TTM) MASS|Net earnings per share (EPS TTM) capsovision.com (CV)|Earnings per share for the last twelve months Rapid Micro Biosystems, Inc. RPID|seer.bio - Earnings per share for the last twelve months|HYPR: Net earnings per share for the last 12 months|Earnings per share for the trailing year FONR (FONAR Corp.)|DXR: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Spectral AI Inc. (MDAI)|Earnings per share for the last twelve months VivoSim Labs|ACON - Net earnings per share for the trailing year|Net earnings per share for the last 12 months AKYA (Akoya Biosciences)|Net earnings per share (EPS TTM) ThermoGenesis Holdings, Inc. (THMO)|Net earnings per share (EPS TTM) TLIS (Talis Biomedical Corporation)|Net earnings per share for the last four quarters T2 Biosystems Inc (TTOO)